News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
233,380 Results
Type
Article (13245)
Company Profile (22)
Press Release (220113)
Section
Business (71309)
Career Advice (1112)
Deals (14422)
Drug Delivery (39)
Drug Development (34478)
Employer Resources (46)
FDA (6581)
Job Trends (5777)
News (125184)
Policy (10315)
Tag
Academia (755)
Alliances (11130)
Alzheimer's disease (512)
Approvals (6627)
Artificial intelligence (89)
Bankruptcy (108)
Best Places to Work (4936)
Breast cancer (148)
Cancer (1077)
Cardiovascular disease (73)
Career advice (884)
Cell therapy (162)
Clinical research (29448)
Collaboration (341)
Compensation (151)
COVID-19 (991)
Data (1092)
Diabetes (113)
Diagnostics (2253)
Earnings (49682)
Events (32604)
Executive appointments (245)
FDA (7086)
Funding (342)
Gene therapy (115)
GLP-1 (390)
Government (1506)
Healthcare (6798)
Infectious disease (1056)
Interviews (194)
IPO (8415)
Job creations (1176)
Job search strategy (771)
Layoffs (154)
Legal (2090)
Lung cancer (179)
Lymphoma (83)
Manufacturing (113)
Medical device (4820)
Medtech (4822)
Mergers & acquisitions (6268)
Metabolic disorders (327)
Neuroscience (724)
NextGen: Class of 2025 (2070)
Non-profit (1529)
Northern California (1114)
Obesity (193)
Opinion (67)
Parkinson's disease (63)
Patents (60)
People (8237)
Phase I (7858)
Phase II (12723)
Phase III (11309)
Pipeline (535)
Postmarket research (1211)
Preclinical (2602)
Radiopharmaceuticals (93)
Rare diseases (160)
Real estate (1322)
Regulatory (7523)
Research institute (774)
Resumes & cover letters (207)
Series A (60)
Southern California (929)
Startups (1133)
United States (9232)
Vaccines (315)
Weight loss (136)
Date
Last 7 days (365)
Last 30 days (1509)
Last 365 days (17631)
2025 (2667)
2024 (16896)
2023 (16187)
2022 (20646)
2021 (20272)
2020 (19028)
2019 (16793)
2018 (12749)
2017 (11970)
2016 (10566)
2015 (12716)
2014 (9228)
2013 (7262)
2012 (7941)
2011 (8061)
2010 (7267)
Location
Africa (317)
Asia (15130)
Australia (2322)
California (2528)
Canada (872)
China (221)
Colorado (113)
Connecticut (167)
Delaware (88)
Europe (33468)
Florida (312)
Georgia (76)
Illinois (206)
Indiana (138)
Japan (87)
Maryland (322)
Massachusetts (1818)
Michigan (68)
Minnesota (117)
New Jersey (743)
New York (718)
North Carolina (342)
Northern California (1114)
Ohio (64)
Pennsylvania (506)
South America (464)
Southern California (929)
Texas (391)
Utah (62)
Virginia (60)
Washington State (272)
233,380 Results for "5".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Mergers & Acquisitions
Pharma Has Kept M&A Spending Small This Year, With Just One Deal Topping $5B
By far, the largest acquisition of 2024 was Novo Holdings’ yet-to-be-closed buyout of manufacturer Catalent at $16.5 billion. Outside of that, the leading pharmaceutical companies kept to less than $5 billion per deal.
December 11, 2024
·
4 min read
·
Annalee Armstrong
Press Releases
Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery
February 20, 2025
·
3 min read
Press Releases
Urinary Retention Market Size to Reach USD 5.5 Billion by 2035, Impelled by Rising Prevalence of Urological Disorders
February 14, 2025
·
9 min read
Deals
Almost 5 Years into $5B Galapagos Partnership, Gilead Execs Start Over With New Spinoff
Five years ago, Gilead signed a massive deal with Galapagos. After a restructuring, the pharma is still hunting for the potential it saw at the original signing.
January 22, 2025
·
5 min read
·
Annalee Armstrong
Press Releases
Varicose Veins Market Size Predicted to Grow at a Steady CAGR of 5.5% during 2025-2035, Impelled by Rising Prevalence of Venous Disorders
February 20, 2025
·
7 min read
Duchenne muscular dystrophy
5 DMD Candidates to Watch in 2025
Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and more aim to deliver the next wave of progress with near-term data and regulatory milestones.
January 27, 2025
·
6 min read
·
Kate Goodwin
Press Releases
BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering
December 16, 2024
·
3 min read
Press Releases
BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering
December 12, 2024
·
4 min read
Press Releases
Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
February 18, 2025
·
8 min read
Press Releases
Enveric Biosciences Announces Closing of $5 Million Public Offering
February 4, 2025
·
5 min read
1 of 23,338
Next
